<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02162615</url>
  </required_header>
  <id_info>
    <org_study_id>SU014</org_study_id>
    <nct_id>NCT02162615</nct_id>
  </id_info>
  <brief_title>Restorelle® Mesh Versus Native Tissue Repair for Prolapse</brief_title>
  <official_title>Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect information on the safety and effectiveness of
      Restorelle Direct Fix mesh and the surgical procedure to implant Restorelle. These results
      will be compared to the safety and effectiveness results in patients who have native tissue
      repair (without mesh) as their pelvic organ prolapse treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of Prolapse</measure>
    <time_frame>12 Month</time_frame>
    <description>Recurrent Prolapse measured anatomically at the target compartment by leading edge of prolapse beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of device and procedure related serious adverse events</measure>
    <time_frame>12 Month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrence of Prolapse</measure>
    <time_frame>12 Month</time_frame>
    <description>Recurrent prolapse is measured anatomically by leading edge of prolapse in the target compartment at or beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of Prolapse</measure>
    <time_frame>36 Month</time_frame>
    <description>Recurrent Prolapse is measured anatomically by leading edge of prolapse in the target compartment beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of Prolapse</measure>
    <time_frame>36 Month</time_frame>
    <description>Recurrent Prolapse measured anatomically by leading edge of prolapse in the target compartment at or beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device or Procedure related AEs of interest</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Additional adverse events</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes in Quality of Life scores for PFDI-20, PISQ-12, and PFIQ-7</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Subjects experiencing vaginal bulge</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rates of revision and/or re-surgery</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">892</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Restorelle Direct Fix A</arm_group_label>
    <description>Anterior/Apical prolapse repair with Restorelle Direct Fix A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native Tissue Repair Anterior</arm_group_label>
    <description>Anterior/Apical prolapse repair with native tissue only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restorelle Direct Fix P</arm_group_label>
    <description>Posterior/Apical prolapse repair with Restorelle Direct Fix P</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native Tissue Repair Posterior</arm_group_label>
    <description>Posterior/Apical prolapse repair with native tissue only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restorelle Direct Fix A</intervention_name>
    <arm_group_label>Restorelle Direct Fix A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restorelle Direct Fix P</intervention_name>
    <arm_group_label>Restorelle Direct Fix P</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Native Tissue Repair Anterior</intervention_name>
    <arm_group_label>Native Tissue Repair Anterior</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Native Tissue Repair Posterior</intervention_name>
    <arm_group_label>Native Tissue Repair Posterior</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult female patients with pelvic organ prolapse who are candidates for transvaginal
        surgical repair.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female at least 18 years of age

          -  Subject has pelvic organ prolapse with leading edge at or beyond the hymen. At or
             beyond the hymen is defined as POP-Q scores of Ba ≥0 and C≥ -1/2 tvl or Bp ≥0 and C≥
             -1/2 tvl

          -  Subject reports a bothersome bulge they can see or feel per PFDI-20 question 3,
             response of 2 or higher (i.e. responses of &quot;somewhat&quot;, &quot;moderately&quot; or &quot;quite a bit&quot;)

          -  Subject is willing to provide written informed consent

          -  Subject is willing and able to comply with the follow-up regimen

        Exclusion Criteria:

          -  Subject is pregnant or intends to become pregnant during the study

          -  Subject has an active or chronic systemic infection including any gynecologic
             infection, untreated urinary tract infection (UTI), or tissue necrosis

          -  Subject has a history of pelvic organ cancer (e.g. uterine, ovarian, bladder, or
             cervical)

          -  Subject has had prior or is currently undergoing radiation, laser therapy, or
             chemotherapy in the pelvic area

          -  Subject has taken systemic steroids (within the last month), or immunosuppressive or
             immunomodulatory treatment (within the last 3 months)

          -  Subject has a systemic connective tissue disease (e.g. scleroderma, systemic lupus
             erythematosus (SLE), Marfan syndrome, Ehlers Danlos, collagenosis, polymyositis or
             polymyalgia rheumatica)

          -  Subject has chronic systemic pain that includes the pelvic area or chronic focal pain
             that involves the pelvis

          -  Subject has uncontrolled diabetes mellitus (DM)

          -  Subject has a known neurologic or medical condition affecting bladder function (e.g.
             multiple sclerosis, spinal cord injury, or stroke with residual neurologic deficit)

          -  Subject is seeking obliterative vaginal surgery as treatment for pelvic organ prolapse
             (colpocleisis)

          -  Subject is not able to conform to the modified dorsal lithotomy position

          -  Subject is currently participating in or plans to participate in another device or
             drug study during this study

          -  Subject has a known sensitivity to polypropylene

          -  Subject has had previous prolapse repair with mesh in the target compartment(s)

          -  Subject is planning to undergo a concomitant prolapse repair in a non-target
             compartment with anything other than native tissue repair
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Lukban, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Pelvic Solutions Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan-Paul Roovers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa Draper</last_name>
    <email>usldr@coloplast.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara Stallman</last_name>
    <email>usbst@coloplast.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sherry Thomas, M.D.</name>
      <address>
        <city>Agoura Hills</city>
        <state>California</state>
        <zip>91301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Louis</last_name>
      <phone>818-991-0988</phone>
    </contact>
    <investigator>
      <last_name>Sherry Thomas, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>SurgOne Pelvic Solutions Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susie Mercer</last_name>
      <phone>720-205-4537</phone>
      <email>smercer@surgone.com</email>
    </contact>
    <investigator>
      <last_name>James Lukban, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luisa Coraluzzi, BSN</last_name>
      <phone>203-785-2164</phone>
    </contact>
    <investigator>
      <last_name>Richard Bercik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Urogynecology and Pelvic Surgery, Christiana Care Health System</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center, National Center for Advanced Pelvic Surgery</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rosemark Women Care Specialists</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Andrew Shapiro</name>
      <address>
        <city>Owings Mills</city>
        <state>Maryland</state>
        <zip>21117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baystate Health System</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Female Pelvic Medicine &amp; Urogynecology Institute of MI</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Beyer Research</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Adult &amp; Pediatric Urology, PC</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Nelson</last_name>
      <phone>402-399-7892</phone>
      <email>research@adultpediatricuro.com</email>
    </contact>
    <investigator>
      <last_name>Rebecca McCrery, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Atlantic Health System</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Pagnillo</last_name>
      <phone>973-971-7267</phone>
    </contact>
    <investigator>
      <last_name>Charbel Salamon, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Research Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Premier Medical Group of Hudson Valley, PC</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Passante</last_name>
      <email>lpassante@premiermedicalhv.com</email>
    </contact>
    <investigator>
      <last_name>Daniel M. Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant Health Urogynecology</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Mackey</last_name>
      <phone>704-574-5157</phone>
    </contact>
    <investigator>
      <last_name>William Porter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Pelvic Health and Continence Center</name>
      <address>
        <city>Hamlet</city>
        <state>North Carolina</state>
        <zip>28345</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Cole</last_name>
      <email>janice.cole@sandhillsregional.com</email>
    </contact>
    <investigator>
      <last_name>Janet Harris-Hicks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant Health Clinical Research</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Akron Urogynecology Associates</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44333</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Institute for Female Pelvic Medicine and Reconstructive Surgery</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcie Taff, RN</last_name>
      <phone>610-435-9575</phone>
      <email>mtaff@fpminstitute.com</email>
    </contact>
    <investigator>
      <last_name>Vincent Lucente, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Women's Health of Lansdale</name>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <zip>19446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Weil</last_name>
      <phone>215-368-1950</phone>
      <email>lweil@cfwoflansdale.com</email>
    </contact>
    <investigator>
      <last_name>Donald DeBrakeleer, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Female Pelvic Health Center</name>
      <address>
        <city>Newtown</city>
        <state>Pennsylvania</state>
        <zip>18940</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Iorio</last_name>
      <phone>215-504-8900</phone>
      <email>jiorio@fphcenter.com</email>
    </contact>
    <investigator>
      <last_name>Stephanie Molden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Wellspan Urogynecology and Pelvic Reconstructive Surgery</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debi Oxenberg, RN</last_name>
      <phone>717-741-8124</phone>
    </contact>
    <contact_backup>
      <last_name>Joan Moore, RN</last_name>
      <phone>717-339-2638</phone>
    </contact_backup>
    <investigator>
      <last_name>Carlos Roberts, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Research</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Wittrock</last_name>
      <phone>605-328-1389</phone>
      <email>jessica.wittrock@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Benson, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Pelvic Health</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Swan Urogynecology</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tabitha Mondrage</last_name>
      <email>tmondrage@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Michael C. Swan, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Texas Urogynecology and Continence Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Baum, WHNP</last_name>
      <phone>512-716-0861</phone>
    </contact>
    <investigator>
      <last_name>Tomas Antonini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scott D. Lauer, DO, PA</name>
      <address>
        <city>Colleyville</city>
        <state>Texas</state>
        <zip>76034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimee Smith</last_name>
      <email>cmadrlauer@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Scott D Lauer, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vermont Urogynecology Associates, P.C.</name>
      <address>
        <city>Williston</city>
        <state>Vermont</state>
        <zip>05495</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic New River Valley</name>
      <address>
        <city>Christiansburg</city>
        <state>Virginia</state>
        <zip>24073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Henderson</last_name>
      <email>sehenderson@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Tamera Howell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Group for Women</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Integrity Medical Research</name>
      <address>
        <city>Mountlake Terrace</city>
        <state>Washington</state>
        <zip>98042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Centre for Advanced Reproductive Endosurgery</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mater Pelvic Health</name>
      <address>
        <city>Pimlico</city>
        <state>Queensland</state>
        <zip>4812</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal Blomme</last_name>
      <email>chantal.blomme@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Susanne Housmans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2VT</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Maisonneuve-Rosemount</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHUS-CRC</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elsie Morneau</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>12827</phone_ext>
      <email>emorneau.chus@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Le-Mai Tu, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lara Taburiaux, MD</last_name>
      <email>larataburiaux@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Michel Cosson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Rumeau</last_name>
      <email>nathalie.rumeau@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Detayrac Renaud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMC Medical Center / Bergman Clinic</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnoud Kastelein</last_name>
      <email>a.w.kastelein@amc.nl</email>
    </contact>
    <investigator>
      <last_name>J.P. Roovers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bergman Clinics</name>
      <address>
        <city>Bilthoven</city>
        <zip>3723 MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karlijn Schweitzer, MD</last_name>
      <email>k.schweitzer@bergmanclinics.nl</email>
    </contact>
    <investigator>
      <last_name>Mariëlla Withagen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amphia Hospital</name>
      <address>
        <city>Breda</city>
        <zip>4819 EV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natasja de Jong</last_name>
      <email>ndejong@amphia.nl</email>
    </contact>
    <investigator>
      <last_name>Jeroen van Bavel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spaarne Gasthuis</name>
      <address>
        <city>Haarlem</city>
        <zip>2035 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Els Hijmans</last_name>
      <email>ehijmans@spaarnegasthuis.nl</email>
    </contact>
    <investigator>
      <last_name>Esther van Swieten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilbert Spaans, MD</last_name>
      <email>wilbert.spaans@mumc.nl</email>
    </contact>
    <investigator>
      <last_name>Wilbert Spaans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Coby van Dam</last_name>
      <email>gyn-rd@antoniusziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Jules Schagen van Leeuwen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anneke Verkleij-Hagoort, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabeth Vernooij, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ISALA</name>
      <address>
        <city>Zwolle</city>
        <zip>8025 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nitolanda van Rijn</last_name>
      <email>n.c.w.van.rijn@isala.nl</email>
    </contact>
    <investigator>
      <last_name>Marian Engberts, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2014</study_first_submitted>
  <study_first_submitted_qc>June 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2014</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pelvic Floor Disorder</keyword>
  <keyword>Pelvic Organ Prolapse</keyword>
  <keyword>Sexual Dysfunction</keyword>
  <keyword>Mesh</keyword>
  <keyword>POP</keyword>
  <keyword>Transvaginal</keyword>
  <keyword>Anterior</keyword>
  <keyword>Posterior</keyword>
  <keyword>Apical</keyword>
  <keyword>Uterine Prolapse</keyword>
  <keyword>Cystocele</keyword>
  <keyword>Rectocele</keyword>
  <keyword>Enterocele</keyword>
  <keyword>Vaginal Vault Prolapse</keyword>
  <keyword>Native Tissue Repair</keyword>
  <keyword>Repair Augmented with Mesh</keyword>
  <keyword>Pathological Conditions, Anatomical</keyword>
  <keyword>Restorelle Direct Fix</keyword>
  <keyword>Vaginal Mesh</keyword>
  <keyword>Transvaginal Mesh</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

